STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. SLS
  4. [EFFECT] SELLAS Life Sciences Group, Inc. SEC Filing

[EFFECT] SELLAS Life Sciences Group, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 25, 2025 5:00 P.M.
Form: S-3
CIK: 0001390478
Company Name: SELLAS Life Sciences Group, Inc.
File Number: 333-290829

Source: View Original Filing on SEC EDGAR

Stock SLS logo
Sellas Life Sciences Group Inc

NASDAQ:SLS

SLS Rankings

#4351 Ranked by Market Cap
N/A Ranked by Dividends

SLS Latest News

Nov 12, 2025
SELLAS Life Sciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Nov 3, 2025
SELLAS Life Sciences Announces Presentation of Phase 2 Data of SLS009 in Combination with Azacitidine and Venetoclax in Relapsed/Refractory AML with MDS-Related Changes (AML-MR) at the 2025 American Society of Hematology (ASH) Annual Meeting
Oct 27, 2025
SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $31 Million in Gross Proceeds
Oct 22, 2025
SELLAS Life Sciences to Participate in the J.P. Morgan U.S. Opportunities Forum
Oct 13, 2025
SELLAS Life Sciences to Present In Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia at the European Society for Medical Oncology (ESMO) Congress 2025

SLS Latest SEC Filings

Nov 21, 2025
[Form 4] SELLAS Life Sciences Group, Inc. Insider Trading Activity
Nov 12, 2025
[8-K] SELLAS Life Sciences Group, Inc. Reports Material Event
Nov 12, 2025
[10-Q] SELLAS Life Sciences Group, Inc. Quarterly Earnings Report
Oct 27, 2025
[424B5] SELLAS Life Sciences Group, Inc. Prospectus Supplement (Debt Securities)
Oct 27, 2025
[8-K] SELLAS Life Sciences Group, Inc. Reports Material Event

SLS Stock Data

205.12M
142.07M
0.32%
25.55%
27.87%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW YORK